Cargando…

Lysosomal TMEM106B interacts with galactosylceramidase to regulate myelin lipid metabolism

TMEM106B is an endolysosomal transmembrane protein not only associated with multiple neurological disorders including frontotemporal dementia, Alzheimer’s disease, and hypomyelinating leukodystrophy but also potentially involved in COVID-19. Additionally, recent studies have identified amyloid fibri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Hideyuki, Perez-Canamas, Azucena, Ye, Hongping, Han, Xianlin, Strittmatter, Stephen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515910/ https://www.ncbi.nlm.nih.gov/pubmed/37745346 http://dx.doi.org/10.1101/2023.09.14.557804

Ejemplares similares

Fronto-temporal dementia risk gene TMEM106B has opposing effects in different lysosomal storage disorders
por: Perez-Canamas, Azucena, et al.
Publicado: (2020)

Lysosomal dysfunction in TMEM106B hypomyelinating leukodystrophy
por: Ito, Yoko, et al.
Publicado: (2018)

The major TMEM106B dementia risk allele affects TMEM106B protein levels and myelin lipid homeostasis in the ageing human hippocampus
por: Lee, Jun Yup, et al.
Publicado: (2023)

The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus
por: Lee, Jun Yup, et al.
Publicado: (2023)

Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice
por: Feng, Tuancheng, et al.
Publicado: (2020)

TMEM106B deficiency impairs cerebellar myelination and synaptic integrity with Purkinje cell loss
por: Feng, Tuancheng, et al.
Publicado: (2022)

Loss of TMEM106B potentiates lysosomal and FTLD‐like pathology in progranulin‐deficient mice
por: Werner, Georg, et al.
Publicado: (2020)

Antibody-recognizing residues 188-211 of TMEM106B exhibit immunohistochemical reactivity with the TMEM106B C-terminal fragment
por: Ishikawa, Ruoyi, et al.
Publicado: (2023)

Lipid‐induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders
por: Gabandé‐Rodríguez, Enrique, et al.
Publicado: (2018)

Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease
por: Perneel, Jolien, et al.
Publicado: (2022)

C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes
por: T. Vicente, Cristina, et al.
Publicado: (2023)

Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency
por: Zhou, Xiaolai, et al.
Publicado: (2017)

TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins
por: Kundu, Samrat T., et al.
Publicado: (2018)

TMEM106B Puncta Is Increased in Multiple Sclerosis Plaques, and Reduced Protein in Mice Results in Delayed Lipid Clearance Following CNS Injury
por: Shafit-Zagardo, Bridget, et al.
Publicado: (2023)

TMEM106A transcriptionally regulated by promoter methylation is involved in invasion and metastasis of hepatocellular carcinoma: TMEM106A is involved in invasion and metastasis of HCC
por: Shi, Shiming, et al.
Publicado: (2022)

β-Galactosylceramidase in cancer: more than a psychosine scavenger
por: Belleri, Mirella, et al.
Publicado: (2022)

Variation in TMEM106B in chronic traumatic encephalopathy
por: Cherry, Jonathan D., et al.
Publicado: (2018)

Reliable and Fast Genotyping Protocol for Galactosylceramidase (Galc) in the Twitcher (Twi) Mouse
por: Carpi, Sara, et al.
Publicado: (2022)

GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease
por: Senkevich, Konstantin, et al.
Publicado: (2022)

Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease
por: Iacono, Diego, et al.
Publicado: (2022)

TMEM106B expression is reduced in Alzheimer’s disease brains
por: Satoh, Jun-ichi, et al.
Publicado: (2014)

Brainstem development requires galactosylceramidase and is critical for pathogenesis in a model of Krabbe disease
por: Weinstock, Nadav I., et al.
Publicado: (2020)

Neuron-specific ablation of the Krabbe disease gene galactosylceramidase in mice results in neurodegeneration
por: Kreher, Conlan, et al.
Publicado: (2022)

TMEM106B aggregation in neurodegenerative diseases: linking genetics to function
por: Jiao, Hai-Shan, et al.
Publicado: (2023)

TMEM106B regulates microglial proliferation and survival in response to demyelination
por: Zhang, Tingting, et al.
Publicado: (2023)

Myelin lipid metabolism and its role in myelination and myelin maintenance
por: Barnes-Vélez, Joseph A., et al.
Publicado: (2022)

In vitro Validation of Chimeric β-Galactosylceramidase Enzymes With Improved Enzymatic Activity and Increased Secretion
por: Ricca, Alessandra, et al.
Publicado: (2020)

TMEM106B a Novel Risk Factor for Frontotemporal Lobar Degeneration
por: van der Zee, Julie, et al.
Publicado: (2011)

TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma
por: Duan, Jicheng, et al.
Publicado: (2021)

TMEM106A inhibits enveloped virus release from cell surface
por: Mao, Dexin, et al.
Publicado: (2022)

Age-dependent formation of TMEM106B amyloid filaments in human brains
por: Schweighauser, Manuel, et al.
Publicado: (2022)

The identification of high-performing antibodies for transmembrane protein 106B (TMEM106B) for use in Western blot, immunoprecipitation, and immunofluorescence
por: Ayoubi, Riham, et al.
Publicado: (2023)

Prion Protein Accumulation in Lipid Rafts of Mouse Aging Brain
por: Agostini, Federica, et al.
Publicado: (2013)

β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease
por: Belleri, Mirella, et al.
Publicado: (2019)

Myelin lipid deficiency: a new key driver of Alzheimer’s disease
por: Qiu, Shulan, et al.
Publicado: (2022)

TMEM106B haplotypes have distinct gene expression patterns in aged brain
por: Ren, Yingxue, et al.
Publicado: (2018)

Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency
por: Arrant, Andrew E., et al.
Publicado: (2018)

A novel, potentially targetable TMEM106B-BRAF fusion in pleomorphic xanthoastrocytoma
por: Hsiao, Susan J., et al.
Publicado: (2017)

Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits
por: Rademakers, Rosa, et al.
Publicado: (2021)

Functional characterization of the lysosomal membrane protein TMEM192 in mice
por: Nguyen, Thuy Linh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rf2fenlhbqnlgi762hdmf6ksji